In (b)(6) 2020, our facility was notified by the fda that patients from one organization had experienced ntm infections (m abscessus) after heart surgery where the cardioquip heater cooler devices were used.This prompted our organization to send samples from our machines to an outside lab for testing.5/8 cardioquip devices came back positive for ntm.Lab results available.We have not identified any related infections at this time.Upon receiving these results, a group convened and learned the following: testing of our 8 devices revealed 5 of 8 machines contaminated with ntm, no known infections with ecmo patients and use of cardioquip in the literature, risk for infection is very low, but not zero.We only use the device to heat-not to cool.Standard work for machine use and cleaning very rigorous, however design of machine is flawed.Next steps include: continued use of the three machines that tested negative, since there is no acceptable substitute.All three will be re-tested, report to fda, connect with the manufacturer, potential retrospective review of 200 ecmo patients.
|